Sign in

You're signed outSign in or to get full access.

Willan

Vice President and Senior Equity Analyst at CJS Securities

Willan is a Vice President and Senior Equity Analyst at CJS Securities, specializing in coverage of public companies across various sectors with a primary focus on mid-cap industrial, consumer, and technology firms. He regularly covers notable companies such as Standex International and WeightWatchers, providing actionable equity research that has been recognized for accuracy and credibility. Willan began his career in investment analysis before joining CJS Securities, where he quickly advanced to his current role, leveraging his expertise to achieve a strong reputation for insightful recommendations and client service. He holds relevant FINRA securities licenses and maintains a solid track record for performance, with positive success rates and industry rankings on platforms like TipRanks.

Willan's questions to Mirion Technologies (MIR) leadership

Question · Q3 2025

Willan asked about Mirion's overall pricing power, specifically whether it is trending differently between the nuclear safety and medical segments.

Answer

Brian Schopfer, EVP, CFO, and Medical Group President, Mirion, reported a $2 million positive price-cost impact in the quarter, attributing it to internal investments in pricing methodologies. He noted a less aggressive pricing approach on the U.S. medical side compared to the nuclear segment, confident in the strong moats around Mirion's product portfolio.

Ask follow-up questions

Fintool

Fintool can predict Mirion Technologies logo MIR's earnings beat/miss a week before the call